Poland Integrated Medicines Management (PL-IMM) - Study Assessing the Provision of Complex Clinical Pharmacy Services to Hospitalized Patients

Trial statusNot yet recruiting
Trial phaseNot applicable
Trial typeInterventional
Biological sexAll
Age18+
SponsorWroclaw Medical University

About this trial

The aim of the study is to assess whether the involvement of a clinical pharmacist in patient care at every stage of hospitalization, from admission to discharge, will improve the quality of healthcare services provided in clinical and economic terms. As part of the research study, we will randomly assign you to two different groups.

Within one group, a pharmacist will be involved in the process of caring for you throughout your hospital stay. The pharmacist will participate in medical rounds, verify medications upon admission to the hospital, check current test results and medical orders regarding pharmacotherapy, verify medications upon discharge and provide advice on the use of medications. All activities will be carried out in consultation with other medical staff. The aim is to check whether such a model of patient care increases safety and leads to improved pharmacotherapy for patients, and also has a positive effect on patient satisfaction and compliance with therapeutic recommendations. Additionally, the opinion of the medical staff and the economic aspects of this solution will be assessed. Within the second group, you will receive standard care offered by the hospital. In the case of both groups, after the hospitalization is completed, the pharmacist will contact you after 1, 3, 6 months to verify your health condition - he or she will ask about any hospitalizations, complications, side effects, and additional visits to the doctor.

Eligibility criteria

This trial does not accept healthy volunteers

Qualifiers

taking ≥4 medicines

taking high risk medicines listed in the medicines reconciliation standard of Polish Society of Clinical Pharmacy (….)

medicine related admission to the hospital within last 12 months

chronic kidney or liver disease

Disqualifiers

age below 18 years old

pregnancy

resident of long-term care facility

unable to express informed consent to participate in the research

Trial design

Design model

Parallel

Treatments tested in this trial

  • multidisciplinary treatment

    Behavioral

    The pharmacist will conduct medication reconciliation at admission, perform medication reviews during the hospital stay and provide drug education to the patient before discharge, as well as written drug information

Treatment groups

610 Participants
are divided into 2 treatment groups
Group A: Control groupNo intervention 0 interventions
Group B: Pharmacist intervention - IMMExperimental treatment 1 intervention

Trial outcomes

Primary outcomes

1

Additional episodes of care

incidence of hospital, emergency department and other unscheduled visits after discharge from hospital during the 6 months follow-up period

Time frame
1, 3 and 6 months after discharge

Secondary outcomes

1

LoS

the length of stay (LoS) in hospital

Time frame
Periprocedural

Other outcomes

1

Interventions

Evaluation of the service by determining the type of interventions performed based on classification of French Society of Clinical Pharmacy

Time frame
Periprocedural
2

Economy

Estimation of the potential financial benefits of the service

Time frame
from first patient enrollment at hospital admission until the end of 6 month follow-up period of the last patient enrolled
3

Patient opinion

The perception of the service by patients based on PSPSQ 2.0 questionnaire

Time frame
at hospital discharge before patient begins the 6 month follow-up period
4

Healthcare team opinion

The perception of the service by healthcare professionals based on questionnaire prepared by research team

Time frame
during the patient's 6 month follow-up period

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

This trial is not recruiting at the moment. You can still explore other options: